Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Empagliflozin in Metabolic Changes Associated With Antiretroviral Therapy in Human Immunodeficiency Virus

NCT07336797 is registered in ClinicalTrials.gov with Abdelrahman Mahmoud as lead sponsor.

NCT NCT07336797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Empagliflozin in Metabolic Changes Associated With Antiretroviral Therapy in Human Immunodeficiency Virus
Lead sponsor
Abdelrahman Mahmoud
Phase
Phase 2
Overall status
Recruiting
Start date
September 1, 2025
Completion date
December 30, 2027
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv (human immunodeficiency virus), metabolic syndrome, obesity & overweight